Aripiprazole tablets have shown good efficacy in the short-term treatment of schizophrenia. Aripiprazole tablets are antipsychotic drugs for the treatment of schizophrenia, and their efficacy in the short-term treatment of schizophrenia has been established in short-term (4- and 6-week) controlled trials in this patient population. Aripiprazole tablets are often used clinically in combination with quetiapine fumarate tablets to improve efficacy. It can also be used with venlafaxine extended-release tablets, risperidone tablets and other drugs. During the use of Aripiprazole Tablets, there is a possibility of adverse reactions such as anorexia, nausea and vomiting, high blood pressure, tachycardia, flu syndrome, chest pain, and painful muscle spasms. The drug is prohibited to be administered to people who are allergic to this drug. During the use of the drug, the patient’s reaction should be closely observed, and in case of suicidal tendencies, dysphagia, postural hypotension, it is necessary to promptly go to the hospital. As a prescription drug, Aripiprazole tablets must be used under the supervision of a medical professional.